| Code | Description | Claims | Beneficiaries | Total Paid |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
3,049 |
3,016 |
$1.93M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
32,604 |
22,796 |
$1.76M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12,449 |
10,995 |
$1.13M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,933 |
21,588 |
$1.07M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,988 |
3,413 |
$432K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,504 |
3,427 |
$404K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,944 |
13,641 |
$389K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13,919 |
13,624 |
$389K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
6,423 |
6,252 |
$382K |
| 59514 |
|
548 |
542 |
$354K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,923 |
6,748 |
$353K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,535 |
3,115 |
$276K |
| 59430 |
|
2,330 |
2,295 |
$253K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12,250 |
11,980 |
$238K |
| 86780 |
|
17,054 |
16,694 |
$182K |
| 87800 |
|
4,865 |
4,705 |
$178K |
| 99215 |
Prolong outpt/office vis |
1,955 |
1,492 |
$171K |
| 76813 |
|
1,493 |
1,465 |
$154K |
| 87653 |
|
5,258 |
5,191 |
$151K |
| 90715 |
|
3,142 |
3,097 |
$145K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,321 |
18,529 |
$121K |
| 81003 |
|
62,266 |
38,967 |
$112K |
| 87340 |
|
11,128 |
10,892 |
$90K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
589 |
574 |
$75K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,181 |
1,156 |
$73K |
| 86762 |
|
5,600 |
5,478 |
$65K |
| 76830 |
Ultrasound, transvaginal |
616 |
579 |
$59K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,120 |
4,936 |
$57K |
| 87088 |
|
8,391 |
8,100 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
636 |
612 |
$53K |
| 86850 |
|
6,023 |
5,890 |
$47K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,530 |
3,411 |
$46K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
685 |
651 |
$44K |
| 86803 |
|
3,293 |
3,208 |
$35K |
| 99000 |
|
2,859 |
2,699 |
$35K |
| 90686 |
|
1,562 |
1,531 |
$31K |
| 87081 |
|
5,325 |
5,241 |
$29K |
| 86696 |
|
1,360 |
1,328 |
$22K |
| 82950 |
|
5,255 |
5,188 |
$20K |
| 76818 |
|
170 |
86 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
620 |
607 |
$15K |
| 86695 |
|
1,364 |
1,329 |
$15K |
| 81001 |
|
6,729 |
6,531 |
$15K |
| 59025 |
Fetal non-stress test |
430 |
341 |
$14K |
| 86900 |
|
5,523 |
5,399 |
$13K |
| 86901 |
|
5,538 |
5,413 |
$13K |
| 99222 |
Initial hospital care, per day, moderate complexity |
133 |
125 |
$13K |
| 84439 |
|
1,795 |
1,723 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
830 |
534 |
$11K |
| 99234 |
|
70 |
69 |
$8K |
| 80053 |
Comprehensive metabolic panel |
914 |
856 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
100 |
98 |
$6K |
| 87480 |
|
460 |
435 |
$5K |
| 87510 |
|
460 |
435 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
69 |
60 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
123 |
63 |
$4K |
| 90658 |
|
189 |
184 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
134 |
109 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
231 |
230 |
$2K |
| 82951 |
|
204 |
196 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
69 |
60 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
96 |
89 |
$2K |
| 76801 |
|
17 |
14 |
$1K |
| 80061 |
Lipid panel |
116 |
114 |
$1K |
| 84702 |
|
96 |
80 |
$1K |
| 54150 |
|
12 |
12 |
$1K |
| 83615 |
|
200 |
182 |
$928.53 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
110 |
103 |
$824.69 |
| 84550 |
|
200 |
182 |
$688.63 |
| 84703 |
|
118 |
115 |
$665.17 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
16 |
13 |
$604.92 |
| 99217 |
|
12 |
12 |
$582.47 |
| 84146 |
|
24 |
24 |
$347.63 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$320.04 |
| 99001 |
|
68 |
59 |
$265.10 |
| 83525 |
|
25 |
25 |
$223.69 |
| 84403 |
|
12 |
12 |
$217.91 |
| S8301 |
Infection control supplies, not otherwise specified |
51 |
45 |
$216.88 |
| 82627 |
|
12 |
12 |
$187.66 |
| 81002 |
|
48 |
30 |
$137.24 |
| 82947 |
|
42 |
41 |
$122.12 |
| 87186 |
|
13 |
12 |
$78.48 |
| 0500F |
|
3,446 |
3,355 |
$0.00 |
| 0501F |
|
287 |
282 |
$0.00 |
| 0503F |
|
2,184 |
2,144 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
638 |
622 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
186 |
179 |
$0.00 |